Ophthalmology

A retinal specialist picks up a syringe, attaches a 30-gauge needle, and enters the eye through the pars plana — a strip of tissue between the iris and the retina. In an adult, that strip is 3.0 to 4.5 millimeters wide. In a premature infant, it’s 1.17 millimeters.

The needle travels 6 to 7 millimeters into the vitreous cavity. There is no tactile feedback. No click, no resistance change, no signal that says you’re in the right place. The physician is navigating by feel, by experience, and by the steadiness of their hand.

This happens 8 to 10 million times a year in the United States alone. It is the most commonly performed eye procedure in the world.

The margins in intravitreal injection are not forgiving. Published anatomy and complication literature tell a consistent story:

One millimeter too anterior — the needle enters the ciliary body. Hemorrhage and pain follow. The procedure stops.

One millimeter too posterior — the needle crosses the ora serrata. Retinal perforation becomes retinal detachment. The patient may need emergency vitrectomy within hours.

One millimeter too deep — the needle contacts the lens. The result is traumatic cataract — an iatrogenic complication that requires its own surgery to repair.

These aren’t theoretical. They’re the documented failure modes of a procedure performed millions of times a year, in a space measured in single-digit millimeters, by a hand holding a syringe designed 170 years ago for a fundamentally different task.

When a physician depresses a standard thumb-plunger syringe, the force travels down the barrel and drives the needle forward. The plunger compresses, the needle lurches, and when the thumb releases, the stopper rebounds — pulling the needle back. This forward-retraction cycle happens with every injection.

In most clinical settings, a millimeter of uncontrolled movement is clinically irrelevant. In the vitreous cavity, it is not.

Forward-retraction movement does something else that doesn’t appear on spec sheets: on the retraction phase, the needle can aspirate vitreous into its tip. On withdrawal, that vitreous strand maintains traction on the retina. Hours or days later, the traction can produce a tear. This is a known mechanism for post-injection retinal detachment.

There is also the question of fatigue. A busy retinal practice may schedule 30 or more intravitreal injections in a single session. Published research shows complication rates double after the 15th procedure (p=0.0001). The hand holding the syringe at 9 AM is not the hand holding it at 3 PM. The syringe doesn’t account for that. It never has.

The thumb-plunger mechanism was designed for gross motor tasks. The thumb is the lowest-dexterity finger on the hand. Physicians compensate — two-handed grips, bracing techniques, slower injection speeds — but these are workarounds for a design that was never intended for microliter precision in a millimeter-scale space.

The Precision Syringe replaces the thumb-plunger with an index-finger actuation mechanism. The index finger — the highest-dexterity finger — controls the plunger from a position closer to the needle tip, in a pencil-like grip.

The biomechanics change in three ways:

Reduced force transmission to the needle. The index-finger mechanism reduces the forward-driving force that causes needle lurch during injection.

One-handed operation. The grip is stable throughout both injection and aspiration. The physician’s second hand remains free to stabilize the eye, hold the speculum, or manage the surgical field.

Standard compatibility. The device uses a standard Luer Lock connection. It accepts the same needles. It fits the same trays. Nothing else in the workflow changes.

The syringe is a single-use disposable — less than one-tenth the cost of robotic-assisted alternatives.

DeLuna et al. published a peer-reviewed study in Clinical Ophthalmology (2019) comparing the Precision Syringe mechanism to a standard thumb-plunger syringe in an ex vivo model.

What was measured: Forward-retraction needle movement — the uncontrolled back-and-forth displacement of the needle tip during plunger actuation.

What they found: 20.9% better needle stability vs. standard thumb-plunger syringe (p=0.04). In absolute terms, a 0.97mm reduction in forward-retraction needle movement.

In an ex vivo model, the device demonstrated reduced needle tip displacement compared to standard technique, indicating improved needle stability under controlled conditions.

What the study did not measure: The study measured needle stability, not clinical outcomes. Volume accuracy showed no significant difference between the two syringes (p=0.28) — both delivered similar volumes. The study was conducted in a sheep eye model with six participants using a hand-built prototype.

What this means: The Precision Syringe has peer-reviewed evidence of improved needle stability. It does not yet have published data on clinical outcomes in human patients. Prospective human studies are in protocol design.

DeLuna D, Netzel A, Dietze J, Begley BA, Ndulue JK, Suh DW. Clinical Ophthalmology. 2019;13:1833-1839.

DeLuna et al. published a peer-reviewed study in Clinical Ophthalmology (2019) comparing the Precision Syringe mechanism to a standard thumb-plunger syringe in an ex vivo model.

What was measured: Forward-retraction needle movement — the uncontrolled back-and-forth displacement of the needle tip during plunger actuation.

What they found: 20.9% better needle stability vs. standard thumb-plunger syringe (p=0.04). In absolute terms, a 0.97mm reduction in forward-retraction needle movement.

In an ex vivo model, the device demonstrated reduced needle tip displacement compared to standard technique, indicating improved needle stability under controlled conditions.

What the study did not measure: The study measured needle stability, not clinical outcomes. Volume accuracy showed no significant difference between the two syringes (p=0.28) — both delivered similar volumes. The study was conducted in a sheep eye model with six participants using a hand-built prototype.

What this means: The Precision Syringe has peer-reviewed evidence of improved needle stability. It does not yet have published data on clinical outcomes in human patients. Prospective human studies are in protocol design.

DeLuna D, Netzel A, Dietze J, Begley BA, Ndulue JK, Suh DW. Clinical Ophthalmology. 2019;13:1833-1839.

The anatomy doesn’t change. The pars plana is still 3 to 4.5 millimeters wide. The needle still travels 6 to 7 millimeters with no feedback. The 15th injection of the day still follows the 14th, and the 30th still follows the 29th.

What changes is the mechanism in the physician’s hand.

For high-volume retinal practices: Session fatigue is a published, quantified risk. A device designed to reduce uncontrolled needle movement addresses the mechanical component of that risk — the part that accumulates with every injection, independent of the physician’s skill or experience.

For pediatric ophthalmology: The infant pars plana can be as narrow as 1.17 millimeters. The clinical margin for error in neonatal intravitreal injection is, in some cases, smaller than the uncontrolled movement a standard syringe produces. The DeLuna paper itself references this anatomical reality.

For every intravitreal injection: The procedure demands millimeter-scale precision from a tool that was designed before anyone imagined putting a needle inside an eye. The Precision Syringe was designed specifically for this mismatch — bringing the instrument closer to the demands of the procedure.

We send samples to ophthalmologists and retinal specialists. No commitment, no purchase required. Hold it. Run it through your injection workflow. See if the difference in control is something your hand notices on the first attempt.

Most physicians who test the device describe the same thing: they stop thinking about the syringe. That’s the point.